Ingersoll Rand Inc. Value Investing Deep-Dive

Fact and Inference. This business does not depend on a single large customer, nor does it obviously depend on a single supplier. The company says most raw materials can be sourced from multiple suppliers, and although some critical components are covered by a small number of long-term contracts and there has been localized single-sourcing in the past, the company has expanded its supplier network for certain materials and parts. For a long-term investor, what really needs watching is not any single customer but the industrial capex cycle, the volatility of life-science orders, and whether newly acquired businesses can be smoothly integrated into the aftermarket system.

Is This a Business I Can Understand

I think it is. It is essentially a multi-brand, mission-critical industrial equipment and aftermarket services company: it sells equipment, and after installation continues to sell parts, consumables, repairs, and services; it then uses small, high-frequency bolt-on acquisitions to gradually weave its channels, product lines, and end markets more tightly together. The complexity lies not in how the products work but in capital allocation and M&A integration. If the stock market were shut for 5 years, I would be willing to own the business itself; but I would not buy it at any price. That distinction matters. In the judgment above, "willing to own the business" is an opinion, while "unwilling to buy heavily at the current price" is a valuation-based inference.

Business Comprehensibility Score: 4/5.

Industry and Moat

Industry and Competitive Landscape

Fact. IR's industry is closer to a combination of "mature industrials plus pockets of growth" than a purely high-growth industry. Demand for compressed air, vacuum, blowers, fluid handling, water treatment, and industrial services exists over the long term, but orders are affected by the health of manufacturing, customer capex, regional economies, and exchange rates, giving them moderate cyclicality; on the other hand, life sciences, water treatment, energy-efficiency improvement, and certain sustainability applications provide structural growth. The company itself positions several of its 2025 acquisitions as bolt-ons into higher-growth, sustainable end markets.

Fact. Competition in the industry is intense but highly fragmented. In its 10-K, IR explicitly writes that although the compression, vacuum, and blower product markets have a number of large manufacturers, the market remains highly fragmented because of the diversity of product technologies, applications, and sales channels. The company lists its main competitors as including Atlas Copco, Flowserve, IDEX, Kaeser, Kaishan, Elgi, and, in Precision and Science Technologies, Dover, Graco, Sartorius, Thermo Fisher, Watson-Marlow, and others.

Inference. This means IR is not in a "winner-take-all" industry but in one where "strong players can keep earning decent returns through brand, applications engineering, channels, and service networks." In other words, it is more of a "good company in a good industry" than a "turnaround in a bad industry"; but it is also not the kind of super-platform with an absolute monopoly moat.

Moat Breakdown

The assessments in the table above are my inferences and opinions about the company's disclosures; their basis includes application criticality, aftermarket share, channel networks, competitive landscape, and recent M&A/impairment facts.

Fact. One genuine part of IR's moat is that its products are often only a "small part" of a customer's total system cost but have a "large impact" on system reliability. In its 10-K the company writes directly that customer systems are often complex, the cost of a failure or shutdown is high, and IR's products typically represent only a small part of total system cost, so customers place a high value on applications expertise, product reliability, and service responsiveness. In addition, $397 million of the company's 2023 revenue growth came from price increases, which shows it is not entirely without inflation pass-through capability.

Fact and Inference. As I see it, the moat is currently stable and widening slightly, but not unconditionally widening. Stability comes from the vast installed base and the aftermarket system; the "slight widening" comes from continual bolt-on acquisitions thickening channels, technology, and end markets; the "potential narrowing" lies in this: if M&A quality declines, or newly acquired businesses fail to meet their original return assumptions, the moat will be eroded by goodwill impairment and low-return capital being tied up. In 2025 the ILC Dover-related business took a $229.7 million goodwill impairment and a $36.1 million tradename impairment, showing that the M&A moat is not monolithic.

Fact. In a downturn, the company's profitability comes under pressure, but for now it can still stay profitable. In 2025 the company had revenue of $7.651 billion, operating income of $1.145 billion, and net income attributable to the parent of $581 million; by Q1 2026, Industrial Technologies and Services saw organic orders and organic revenue fall 2.6% and 1.6% respectively, and that segment's adjusted EBITDA margin declined 210 basis points year over year to 26.7%, showing that margins get compressed when the cycle turns down.

My assessment: This is not a network-effect super-moat but a composite moat of "application criticality + aftermarket installed base + global service network + brand and engineering capability." It genuinely exists, but it is limited in width and still requires continued execution by management.

Industry Attractiveness Score: 4/5. Moat Strength Score: 3.5/5.

Management and Capital Allocation

Is Management Trustworthy

Fact. CEO Vicente Reynal has served as the company's CEO, President, and a director since 2016, and has also served as Chairman since 2021. On governance, the company has majority voting, no supermajority voting requirements, an anti-hedging/anti-pledging policy, and an incentive clawback policy; the 2025 shareholder support for say-on-pay was 96%. Management and directors are also bound by strict stock ownership guidelines: the CEO must hold shares equal to 10x annual salary, the CFO and General Counsel 5x, and other executives who report directly to the CEO 2x to 3x; as of the end of 2025, all eligible NEOs and directors met this requirement.

Fact. But in terms of "whether interests are highly aligned with shareholders," it is only moderately favorable, not extremely strong. As of April 16, 2026, the CEO held about 1.26 million shares, and all current directors and officers together held about 1.92 million shares, against roughly 391.3 million shares outstanding on that date; that is, the dollar value of the CEO's personal holding is not small, but the entire management team's ownership stake is still under 1%. This is far weaker than at many founder-led companies.

Is Capital Allocation Rational

Fact. Over the past three years, the company's uses of cash have been very distinct: M&A, buybacks, a small dividend, and debt management in parallel. In 2025, operating cash flow was $1.356 billion, capex was $135.6 million, net cash used for M&A was $525 million, share buybacks were $1.018 billion, and common-stock cash dividends were only $31.8 million. In 2024, because of acquisitions such as ILC Dover, net cash used for M&A reached as high as $2.959 billion, with $260.7 million of buybacks at the same time, funded through $3.297 billion of new long-term debt.

Fact and Inference. On buybacks, management has indeed brought the share count down: diluted weighted-average shares fell from 409 million in 2023 to 401 million in 2025, and dropped further to 394 million in Q1 2026. The problem is that the buyback prices have not been conservative. In 2025 the company repurchased 12.687 million shares at an average price of $79.40; in 2024 it repurchased 2.665 million shares at an average price of $93.80; while the current share price is about $70.96, below the 2025 average buyback price and far below the 2024 average. In other words, buybacks reduced the share count, but they do not prove that management is particularly skilled at repurchasing when undervalued.

Fact. On M&A, the company clearly runs itself as an "industrial compounding platform." In 2024 it completed the ILC Dover acquisition, with initial cash consideration of $2.3497 billion; in 2025 it continued to complete multiple acquisitions such as SSI, TMIC/Adicomp, and Transvac. In its annual report, the company explains that in 2025 it continued to focus on strengthening its core categories and its exposure to high-growth, sustainable end markets through M&A.

Fact and Inference. But the evidence that M&A creates value is mixed, not overwhelmingly excellent. The strongest negative evidence is that the ILC Dover-related business, shortly after the acquisition closed, recognized in 2025 a $229.7 million goodwill impairment and a $36.1 million indefinite-lived tradename impairment; the company discloses that the reasons include a higher discount rate, contraction in market multiples, and a downward revision of the long-term forecast for the Aerospace & Defense business due to reduced business from an important customer. For a long-term owner, this shows that management is not immune to mistakes, and that M&A returns are more sensitive to the external environment and to individual customers than is ideal.

My conclusion: In governance structure, incentive design, and operational execution, management is generally competent, even above the average industrial company; but on capital allocation I do not give a high score, the core reasons being the impairment fact after a large acquisition and the high-priced buybacks when the stock was not obviously undervalued.

Management and Capital Allocation Score: 3/5.

Financial Quality and Owner Earnings

Key Financial Metrics

The table below is compiled from the company's 2023 and 2025 10-K, the Q1 2026 10-Q, and the historical adjusted data in the appendix to the 2026 proxy materials; margins and some ratios are derived by me on a consistent basis. All amounts are in millions of dollars, except per-share figures and ratios.

My Assessment of Financial Quality

Fact. From 2021 to 2025, revenue grew from $5.152 billion to $7.651 billion, a compound growth rate of roughly 10%; free cash flow grew from $564 million to $1.220 billion, an even more pronounced increase. Gross margin also improved from about 38.6% to around 43%, showing that product mix, price increases, and M&A combined with the aftermarket business did improve earnings quality.

But it must be stressed: this growth is not all organic. In 2025 the company's revenue grew 5.7% year over year, mainly from $419.9 million of M&A and a $92 million FX tailwind, while organic revenue actually declined by $96 million. By Q1 2026, the Industrial Technologies and Services segment saw organic orders fall 2.6% and organic revenue fall 1.6%, with the segment's adjusted EBITDA margin declining to 26.7%. So if you view IR as a "purely organic compounder," you will overstate its business quality. The more accurate view is: it is a compounding platform of "an excellent chassis plus obvious reliance on M&A to enhance it."

Fact. Capex intensity is very low. From 2023 to 2025, capex was $105 million, $149 million, and $136 million respectively, only about 1.5%–2.1% of revenue. This shows the company's growth does not require heavy, continual asset investment. Where it truly consumes capital is not plants but M&A.

Fact. Accounting profit and cash flow are broadly matched, and "cash is even stronger." From 2021 to 2025, free cash flow was close to or higher than net income to the parent every year; however, there are two factors here that need to be viewed calmly: first, the company has ongoing large-scale amortization of intangibles from acquisitions, with intangible amortization reaching $387.5 million in 2025; second, 2025 also saw a $273.4 million goodwill/other intangible impairment, plus a $127.1 million equity-method investment loss, items that depressed net income but did not directly consume current operating cash. For this reason, the 2025 phenomenon of "FCF far above net income" cannot simply be equated with "an extraordinarily impressive cash cow," and is more like "GAAP profit understated under acquisition accounting."

Fact. The balance sheet still looked solid in Q1 2026. The company had cash of $1.274 billion, total debt of $4.779 billion, and net debt of about $3.504 billion; it had no undrawn draws on its revolving facility, a $2.6 billion revolver and a $2.6 billion commercial paper program, and met all debt covenants. The net leverage limit on the company's revolving credit is 3.50x, and on my rough calculation using the company's disclosed 2025 adjusted EBITDA and Q1 2026 adjusted EBITDA, net debt to trailing-twelve-month adjusted EBITDA is about 1.7x, clearly below the covenant ceiling.

Fact. Working capital tied up noticeably more cash in 2025. The company discloses that operating working capital rose from $1.419 billion at the end of 2024 to $1.609 billion at the end of 2025, rising from 19.6% to 21.0% of revenue, mainly because of increases in receivables, inventory, and contract assets. By Q1 2026, inventory continued rising to $1.236 billion, while accounts payable fell from $996 million at the end of 2025 to $847 million, and seasonal working-capital pressure remained. Over the long term this is not a danger signal, but it shows that this company is not entirely "free of working-capital burden."

Fact and Judgment. I do not see obvious signs of financial fraud: receivables credit risk is dispersed, and the bad-debt allowance is not abnormal in size; but what I do see is the accounting complexity typical of an "acquisitive industrial company," with large amounts of goodwill, customer-relationship and tradename intangibles, layered with purchase-accounting adjustments, integration costs, and impairment tests from frequent acquisitions. For this kind of company, the biggest accounting risk is usually not fabricated revenue but "overpaying on acquisitions, which dilutes future returns and later shows up through impairments."

Owner Earnings Estimate

First, separate facts and assumptions:

The facts above come from the company's financial statements; the Owner Earnings figure is a conservative inference I have made based on these facts.

Against the current market cap of about $27.77 billion, IR trades at about 23.8x conservative owner earnings; without deducting stock-based compensation, it trades at about 22.8x free cash flow. On either basis, this is not a price so cheap that "you can make money even if you are wrong."

Financial Quality Score: 4/5. This score is higher than the management score, because the business itself does have strong cash flow, light capex, and controllable debt; but it is below a "top-tier compounder," because growth relies fairly heavily on M&A and there is already a clear impairment lesson in 2025.

Intrinsic Value and Margin of Safety

Facts, Assumptions, Inferences, Opinions

Before valuing, let me first make the boundaries clear:

• Fact: The current share price is about $70.96 and market cap about $27.77 billion; 2025 free cash flow was $1.220 billion; my conservatively estimated owner earnings are about $1.167 billion; Q1 2026 net debt was about $3.504 billion.

• Assumption: Over the next 10 years the company can sustain 3%–7% owner-earnings growth; the discount rate is taken at 8.5%–10%; the terminal growth rate is taken at 2.5%–3.5%.

• Inference: The current price broadly reflects neutral-to-somewhat-optimistic execution expectations.

• Opinion: For a balanced, somewhat conservative investor, a more obvious discount should be required.

Method One: Owner Earnings Discount Model

The following model starts from conservative Owner Earnings of $1.167 billion, and uses about 391.3 million shares as the per-share basis; since Owner Earnings is already on a shareholder-available basis, I estimate equity value directly. The figures are a valuation range I derive from the assumptions above, not company guidance.

My reading: At the current $70.96 share price, IR sits roughly at the upper edge of my "fair value range," with comfortable upside only near the optimistic scenario; this is not a typical deep-value mispricing but more like "the market has already recognized it as a good company and prepaid part of its future execution results."

Method Two: Relative Valuation

The relative valuation below prioritizes the latest market prices and each company's most recent annual free cash flow/earnings data. IR's P/E is significantly distorted by the 2025 impairments and equity-method losses, so P/FCF and EV/EBITDA deserve more attention.

IR's relative conclusion is not simple. On GAAP P/E it looks very expensive; on P/FCF it is no more expensive than the group of quality industrials, and even slightly below Dover and IDEX; and considering IR's current roughly 14.9x trailing-twelve-month adjusted EBITDA, it is no longer cheap but also not an extreme bubble. My conclusion is: the current valuation is "on the expensive side but not absurd," and the core issue is a lack of margin of safety, not an absolute overvaluation that guarantees a pullback.

Method Three: Asset and Liquidation Value

Fact. As of March 31, 2026, the company had total assets of about $18.218 billion, goodwill of $8.471 billion, other intangibles of $4.143 billion, and total shareholders' equity of $10.240 billion. In other words, goodwill and intangibles together already exceed $12.6 billion, clearly above book equity; on a "tangible net asset" basis, the company has no meaningful asset cushion, and is instead close to negative tangible net worth.

Inference. This shows that IR's investment logic is by no means "paying fifty cents for a dollar of net assets," but must rest on "the enterprise continuing to operate and keep generating high-quality cash flow." If future M&A returns keep declining, the goodwill and intangibles on the books will turn from a "prepayment on future earnings" into a "source of value evaporation." This is also an important reason I lean cautious on margin of safety.

Margin of Safety Assessment

Conservative intrinsic value range: $40–50 Fair intrinsic value range: $55–70 Optimistic intrinsic value range: $80–90 Current price relative to fair intrinsic value: near the upper edge, margin of safety not clear Ideal buy price range: $45–55 Acceptable holding price range: $55–70 Clearly overvalued price range: above $80

The ranges above do not represent precise points but are my approximate judgment of the "price range I would be willing to pay to buy the whole company." If growth comes in below expectations, margins keep facing pressure, or the valuation multiple falls back to a more ordinary industrial-stock level, the return from buying today will be mediocre; this is exactly the classic form of "a good company at a bad price."

Risks, Comparison, Checklist, and Final Verdict

Risks and the Strongest Counterargument

The most important risks:

• M&A risk: The company's growth depends heavily on M&A; the goodwill and tradename impairments a year after the ILC Dover acquisition already provide the clearest risk sample.

• Valuation risk: The current share price is not cheap, and the organic-growth evidence for 2025–2026 is not strong; if the market re-rates it from an "industrial compounding platform" to an "ordinary quality industrial stock," the multiple could contract.

• Cycle risk: The ITS segment saw organic orders and revenue turn negative in Q1 2026 with margins declining, showing that once macro demand weakens, profitability gets squeezed.

• Working-capital risk: In 2025 receivables, inventory, and contract assets rose, and working capital as a share of revenue increased; cash flow is not entirely immune to order timing.

• Accounting and balance-sheet risk: Goodwill and intangibles make up an extremely high share of assets, and the asset-based safety cushion is thin.

• Interest-rate and discount-rate risk: The 2025 impairments were clearly linked to a rising discount rate and contracting market multiples; a high-rate environment compresses both M&A returns and valuation at the same time.

The strongest counterargument is: "IR is an M&A-driven industrial platform priced by the market as a high-quality industrial compounding machine, not a top-tier moat business in Buffett's sense. Its legacy business is decent but not irreplaceable; its valuation holds only if management keeps making high-return acquisitions using not-cheap equity/capital, and ILC Dover has already shown that this path is not always smooth. Given that the U.S. 10-year Treasury yield is about 4.50% and the effective yield on AAA U.S. corporate bonds is about 5.02%, why, at the current price, take on the compounded risk of a single stock, M&A missteps, and multiple compression?" I consider this counterargument to have force.

Which facts would overturn the investment judgment:

• If over the next 12–24 months the ITS segment's organic orders and margins recover clearly, and M&A returns are again proven by facts to exceed the cost of capital, my tolerance for the valuation would increase.

• If the company again takes an impairment within a short time after a large acquisition, or net debt/EBITDA rises clearly without improved returns, I would further lower my long-term valuation.

• If aftermarket revenue share keeps declining, customer churn accelerates, or the service-network advantage weakens, I would conclude the moat is narrowing.

Comparison with Other Opportunities

Compared with the industry's strongest competitor, Atlas Copco. IR itself lists Atlas Copco as one of its main competitors in the 10-K. Atlas Copco is larger, with a market cap of about $90.7 billion at the end of 2025, and Yahoo shows its ADR at about 33.8x P/E; the company also discloses that it completed 29 acquisitions in 2025, with R&D spending of about 4% of revenue. From a long-term owner's perspective, I am more willing to acknowledge that Atlas Copco's moat and capital-allocation stability are stronger; IR's advantage usually only appears when it is "clearly cheaper on valuation," rather than in the current state of merely "slightly below top-tier peers but not cheap."

Compared with a broad index. SPY is currently about $750.46. IR is a high-quality single industrial stock, but at the current price it is not obviously cheap enough for me to say "buying it is clearly better than buying the index." The index gives you greater diversification, while IR additionally carries the single-point risk of M&A execution, industry cycles, customer structure, and management capital allocation. This comparison is more of an opinion and inference, but it rests on the fact that IR's current valuation is not cheap.

Compared with the risk-free rate and high-grade bonds. When the 10-year Treasury is about 4.50% and the effective yield on AAA U.S. corporate bonds is about 5.02%, if IR can only offer mid-single-digit to high-single-digit expected annualized returns, its appeal to conservative capital is not that strong. Only when the price is lower and expected returns open up a bigger gap over bond yields is it more worth tying up your capital.

Investment Checklist

Final Investment Conclusion

【Final Rating】 Watch

【One-Sentence Investment Thesis】 This is an industrial compounder of decent quality, with solid cash flow and an installed-base-and-service moat, but the current price already assigns non-trivial expectations to future execution, and the margin of safety is insufficient.

【Core Bull Case】 First, the products have application criticality with high downtime cost, while a single unit's cost is low relative to the customer's overall system, which naturally supports services and some pricing power. Second, the installed base brings significant aftermarket revenue, with aftermarket revenue at 36.5% in 2025, making the revenue mix more stable than a traditional one-time equipment vendor. Third, capex intensity is low and free cash flow has stayed strong, with FCF rising from $564 million to $1.220 billion between 2021 and 2025. Fourth, leverage is currently manageable, with no revolver draws in Q1 2026 and net debt/TTM adjusted EBITDA roughly around 1.7x. Fifth, the governance and incentive framework is fairly disciplined, with well-developed stock-ownership requirements, clawback, and anti-hedging policies.

【Core Bear Case】 First, the valuation has no clear discount, with the current share price roughly at the upper edge of my fair value range. Second, growth relies heavily on M&A; organic revenue was negative in 2025, and ITS organic orders and revenue were also declining in Q1 2026. Third, an impairment after a large acquisition has already occurred, with the ILC Dover-related business recognizing goodwill and tradename impairments in 2025. Fourth, goodwill and intangibles are a high share, the tangible-asset cushion is thin, and it is unsuitable for conservative investors who think in asset-based terms. Fifth, although buybacks reduced the share count, they clearly did not occur in an undervalued zone, so capital allocation cannot score full marks.

【Key Assumptions】 The company can sustain Owner Earnings growth of mid-single-digits or higher; Aftermarket revenue share does not decline and ITS margins can recover; Future M&A returns overall exceed the cost of capital, with no more frequent large impairments; Net debt/EBITDA stays in a prudent range. These are all assumptions, not facts that have already occurred.

【Fair Buy Price】 $45–55. The basis: this range roughly corresponds to applying a 20%–25% discount to my neutral intrinsic value of $55–70, and is better suited to balanced, somewhat conservative investors with a holding period of 10 years or more.

【Target Holding Period】 More than 10 years, but on the condition of buying at a price with a margin of safety, rather than being "forced to hold long term" at a fair-to-somewhat-expensive price.

【Expected Annualized Return】 Conservative scenario: 1%–4% Neutral scenario: 5%–7% Optimistic scenario: 8%–10% This is an inference I make based on the current price, future Owner Earnings growth, and terminal-multiple assumptions, not a company promise. At the current price, the conservative and neutral returns are not especially attractive against bond yields.

【Maximum Loss Risk】 If M&A returns keep coming in below expectations, ITS organic growth keeps weakening, and the market re-rates IR from a "high-quality industrial compounder" to an "ordinary quality industrial stock," it is not hard to imagine the share price falling back to $40–50, which would mean roughly 30%–45% downside from the current price. Such a loss would not necessarily come from a business collapse but more likely from "buying too expensively." This is the most classic permanent-capital-loss scenario.

【Tracking Metrics】 Going forward I will focus on tracking: The ITS segment's organic orders and organic revenue; The company's overall aftermarket revenue share; The recovery of the ILC Dover-related business within the PST segment; Adjusted EBITDA margin and ITS margin; Operating cash flow and working capital as a share of revenue; Annual M&A amounts, and ROIC/impairment one year after acquisitions; Net debt/EBITDA; Changes in diluted share count and average buyback price; Changes in large customers, especially the important A&D-business customer management has already flagged; Whether capital-allocation priorities continue to put "growth in per-share intrinsic value for shareholders" ahead of "scale expansion."

【Signals That Trigger Reassessment】 Another major post-acquisition impairment; Aftermarket share declining for consecutive periods; ITS margin failing over the long term to return to the upper part of its historical high-20s range; Net debt/EBITDA rising persistently; Buybacks continuing during clearly overvalued phases alongside large-scale M&A; Management beginning to emphasize scale over per-share value; Free cash flow being eroded over the long term by working capital or integration costs.

【Final Recommendation】 If you think of yourself as someone who wants to own a business over the long term, rather than someone trying to guess next month's share price, then IR deserves a place on a high-quality industrials watch list and is worth tracking continually; but at today's price, I would rather define it as a company you "can admire, can wait for, but need not rush to buy." Truly good value investing does not stop at asking whether the company is good; it asks: does the price this good business offers me today still allow me to avoid serious harm even if my judgment is off. For IR, my current answer is: the business is fine, the price is average, and the margin of safety is not enough.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.